7Vasir J K, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics[J]. Adv Drug Deliv Rev,2007,59(8) :718-728.
8Mundargi R C, Babu V R, Rangaswamy V, et al. Nano/micro technologies for delivering macromolecular therapeutics using poly ( D, L-lactide-co-glycolide) and its derivatives [ J]. J Controlled Release, 2008, 125(3) : 193-209.
9Eley J G, Mathew P. Preparation and release characteristics of insulin and insulin-like growth factor-one from polymer nanoparticles[J]. J Microencapsul, 2007,24( 3 ) : 225-234-.
10Abeylath S C, Turos E. Glycosylated polyacrylate nanoparticles by emulsion polymerization [ J ]. Carbohydr Polym, 2007,70 ( 1 ) : 32-37.
7Mailer R H, Mader K, Gohla S. Solid lipid nanopartieles ( SLN ) for controlled drug delivery --a review of the state of the art[ J]. Eur J Pharm Biopharm ,2000,50 ( 1 ) : 161-177.
8Mehnert W, Madex K. Solid lipid nanoparticles : production, charac- terization and applications [ J ]. Adv Drug Deliv Rev, 2001,47 ( 2- 3 ): 165-!96.
9Ahlin P,Kfistl J, Sentjure M, et al. Influence of spin probe struc- ture on its distribution in SLN dispersions[ J]. Int J Pharm,2000, 196(2) :241-244.
10Muller R H ,Radtke M ,Wissing S A. Nanostructured lipid matrices for improved microencapsulation of drugs [ J ]. Int J Pharm,2002, 242(1-2) :121-128.
